Way Towards New Life

Named Patient Programs

Alleviare promptly facilitates Indian patients and physicians under Named Patient Programs (NPP) to access imported authorized medicines that are not locally available to them.

Access Under Named Patient Programs

Drugs for Hematological Malignancies

Here is a list of some of the products for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

Darbepoetin alfa injection

Darbepoetin may be used for patients on kidney dialysis or for those not on dialysis. Darbepoetin alfa is used to treat severe anemia in these patients.

Blinatumomab for injection

Indicated for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults and children

Pralatrexate injection

Pralatrexate is approved to treat Peripheral T-cell lymphoma in patients whose disease is refractory (does not respond to treatment) or has recurred.

Panobinostat) capsules

It’s used to treat multiple myeloma, which is a type of cancer that affects plasma cells. These are a kind of white blood cell.

Access Under Named Patient Programs

Oncology (Cancer) Medications

Here is a list of some of the products for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

Apalutamide Tablets

It’s used to treat these types of prostate cancer in adult males: Nonmetastatic castration-resistant prostate cancer (nmCRPC).

Vemurafenib Tablet

It is approved to treat patients whose cancer has a certain mutation in the BRAF gene, including: Erdheim-Chester disease, Melanoma.

Rucaparib Tablets

Rucaparib camsylate is approved to treat: Ovarian epithelial, fallopian tube, or primary peritoneal cancer, Prostate cancer.

Tivozanib Capsules

Indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following

Access Under Named Patient Programs

Specialty Drugs

Here is a list of some of the products for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

Lanadelumab For Injection

Approved the use of lanadelumab in August 2018, for people that are 12 years and older and have either type I or type II hereditary angioedema.

Valbenazine Capsules

It is a medication used to treat tardive dyskinesia. It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor.

Letermovir Injection

indicated for prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant (HSCT).

Olaratumab Injection

used to treat adults with advanced soft tissue sarcoma, a type of cancer that affects the soft, supportive tissues of the body such as muscles, blood vessels and fat tissue.
Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.

Alleviare Life Sciences Pvt. Ltd.

Alleviare  serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Testimonials

I would like to thank Mr. Kamal and his team for all the help that extends to us for the import of Lonesurf medicine for my father. It was a great experience working with you and your firm (Aleviare India Delhi).

5/5

Subhash Bishnoi

Businessman

We requested ALLEVIARE INDIA Delhi to import the drug from Canada. ALLEVIARE INDIA arranged to get an import license immediately and ordered the medicine and informed us of the result at all times.We acknowledge the prompt efforts of ALLEVIARE INDIA.

5/5

Saurabh Kaushik

Manager

On behalf of the entire Organizing Committee of the 5th International Primary Immunity Disorders Conference held at The Leela Delhi, we would like to express our gratitude and gratitude for the valuable cooperation provided by ALLEVIARE INDIA in making this conference a major success.

5/5

Ramesh Tripathi

Coordinator

Query Form

We would love to speak with you.
Feel free to reach out using the below details.

Access Unauthorized Medicines In India Under NPP.

What is Named-patient access programme (NPP)?

Named-patient basis access can also refer to a medicine for a specific patient or patients that is not (yet) authorised and available to them in their own country. Such medicine should or must (depending on legislation) be authorised in at least one country, from which it can be imported into the patient’s country under a Named-patient access programme (NPP).

These may be medicines that are:

  • Authorised but not yet available to be prescribed in the patient’s country.
  • Authorised and available in one country but not authorised and available in the patient’s country.
  • Discontinued in the patient’s country but not in another country.
  • In shortage in the patient’s country but not in another country.